Lithium;4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoic acid;methyl 4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoate;hydroxide
C155H267LiN24O33S2 — CID 162246734
Data last refreshed: (MolForge compound catalog, from PubChem)
About Lithium;4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoic acid;methyl 4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoate;hydroxide
Lithium;4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoic acid;methyl 4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoate;hydroxide (PubChem CID 162246734) has the molecular formula C155H267LiN24O33S2 and a molecular weight of 3066.05 g/mol. Its IUPAC name is lithium;4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoic acid;methyl 4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoate;hydroxide.
Molecular Properties
| Compound Name | Lithium;4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoic acid;methyl 4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoate;hydroxide |
|---|---|
| PubChem CID | 162246734 |
| Molecular Formula | C155H267LiN24O33S2 |
| Molecular Weight | 3066.05 g/mol |
| Exact Mass | 3063.96 |
| IUPAC Name | lithium;4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoic acid;methyl 4-[[(7R,8R)-8-[(2S,5S,8S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-8-(4-hydroxybutylsulfanylmethyl)-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]carbamoyl]benzoate;hydroxide |
| SMILES | CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CCCCCCNC(=O)c2ccc(C(=O)O)cc2)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CSCCCCO)N(C)C1=O.CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CCCCCCNC(=O)c2ccc(C(=O)OC)cc2)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CSCCCCO)N(C)C1=O.[Li+].[OH-] |
| InChI | InChI=1S/C78H134N12O16S.C77H132N12O16S.Li.H2O/c1-25-56-72(99)88(21)61(44-107-39-31-30-38-91)75(102)84(17)58(41-46(4)5)69(96)83-62(49(10)11)76(103)85(18)57(40-45(2)3)68(95)80-52(15)66(93)81-53(16)71(98)86(19)59(42-47(6)7)73(100)87(20)60(43-48(8)9)74(101)89(22)63(50(12)13)77(104)90(23)64(70(97)82-56)65(92)51(14)32-28-26-27-29-37-79-67(94)54-33-35-55(36-34-54)78(105)106-24;1-24-55-71(98)87(21)60(43-106-38-30-29-37-90)74(101)83(17)57(40-45(4)5)68(95)82-61(48(10)11)75(102)84(18)56(39-44(2)3)67(94)79-51(15)65(92)80-52(16)70(97)85(19)58(41-46(6)7)72(99)86(20)59(42-47(8)9)73(100)88(22)62(49(12)13)76(103)89(23)63(69(96)81-55)64(91)50(14)31-27-25-26-28-36-78-66(93)53-32-34-54(35-33-53)77(104)105;;/h33-36,45-53,56-65,91-92H,25-32,37-44H2,1-24H3,(H,79,94)(H,80,95)(H,81,93)(H,82,97)(H,83,96);32-35,44-52,55-64,90-91H,24-31,36-43H2,1-23H3,(H,78,93)(H,79,94)(H,80,92)(H,81,96)(H,82,95)(H,104,105);;1H2/q;;+1;/p-1/t51-,52+,53-,56+,57+,58+,59+,60+,61-,62+,63+,64+,65-;50-,51+,52-,55+,56+,57+,58+,59+,60-,61+,62+,63+,64-;;/m11../s1 |
| InChIKey | ZXKZQTJGMGYREQ-IXBATURJSA-M |
| XLogP | 7.43 |
| TPSA | 749.86 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 56 |
| Heavy Atoms | 215 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3066.05 |
| LogP ≤ 5 | 7.43 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 34 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162246734 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.